Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?. Gudiol, C., Lewis, R. E, Strati, P., & Kontoyiannis, D. P The Lancet Haematology, 8(3):e216 – e228, 2021. Cited by: 52![Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection? [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi bibtex @ARTICLE{Gudiol2021e216,
author = {Gudiol, Carlota and Lewis, Russell E and Strati, Paolo and Kontoyiannis, Dimitrios P},
title = {Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?},
year = {2021},
journal = {The Lancet Haematology},
volume = {8},
number = {3},
pages = {e216 – e228},
doi = {10.1016/S2352-3026(20)30376-8},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100083313&doi=10.1016%2fS2352-3026%2820%2930376-8&partnerID=40&md5=26b61b5afabf45f1f99cb5fbcad3ff69},
type = {Review},
publication_stage = {Final},
source = {Scopus},
note = {Cited by: 52}
}
Downloads: 0
{"_id":"MfTerotSRe6guWjxm","bibbaseid":"gudiol-lewis-strati-kontoyiannis-chimericantigenreceptortcelltherapyforthetreatmentoflymphoidmalignanciesisthereanexcessriskforinfection-2021","author_short":["Gudiol, C.","Lewis, R. E","Strati, P.","Kontoyiannis, D. P"],"bibdata":{"bibtype":"article","type":"Review","author":[{"propositions":[],"lastnames":["Gudiol"],"firstnames":["Carlota"],"suffixes":[]},{"propositions":[],"lastnames":["Lewis"],"firstnames":["Russell","E"],"suffixes":[]},{"propositions":[],"lastnames":["Strati"],"firstnames":["Paolo"],"suffixes":[]},{"propositions":[],"lastnames":["Kontoyiannis"],"firstnames":["Dimitrios","P"],"suffixes":[]}],"title":"Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?","year":"2021","journal":"The Lancet Haematology","volume":"8","number":"3","pages":"e216 – e228","doi":"10.1016/S2352-3026(20)30376-8","url":"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100083313&doi=10.1016%2fS2352-3026%2820%2930376-8&partnerID=40&md5=26b61b5afabf45f1f99cb5fbcad3ff69","publication_stage":"Final","source":"Scopus","note":"Cited by: 52","bibtex":"@ARTICLE{Gudiol2021e216,\n\tauthor = {Gudiol, Carlota and Lewis, Russell E and Strati, Paolo and Kontoyiannis, Dimitrios P},\n\ttitle = {Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?},\n\tyear = {2021},\n\tjournal = {The Lancet Haematology},\n\tvolume = {8},\n\tnumber = {3},\n\tpages = {e216 – e228},\n\tdoi = {10.1016/S2352-3026(20)30376-8},\n\turl = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100083313&doi=10.1016%2fS2352-3026%2820%2930376-8&partnerID=40&md5=26b61b5afabf45f1f99cb5fbcad3ff69},\n\ttype = {Review},\n\tpublication_stage = {Final},\n\tsource = {Scopus},\n\tnote = {Cited by: 52}\n}\n\n","author_short":["Gudiol, C.","Lewis, R. E","Strati, P.","Kontoyiannis, D. P"],"key":"Gudiol2021e216","id":"Gudiol2021e216","bibbaseid":"gudiol-lewis-strati-kontoyiannis-chimericantigenreceptortcelltherapyforthetreatmentoflymphoidmalignanciesisthereanexcessriskforinfection-2021","role":"author","urls":{"Paper":"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100083313&doi=10.1016%2fS2352-3026%2820%2930376-8&partnerID=40&md5=26b61b5afabf45f1f99cb5fbcad3ff69"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/z9HzMuFfTZBTCahC4/scopus.bib","dataSources":["jKN7prtxaY9N8vqst","qLqjc4bwMYLmk2F3c","8E62bsJiEchQrmW6z","NcXuTqLcAyFRTYR5S","Q7T46e3zk4SYE595H"],"keywords":[],"search_terms":["chimeric","antigen","receptor","cell","therapy","treatment","lymphoid","malignancies","excess","risk","infection","gudiol","lewis","strati","kontoyiannis"],"title":"Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?","year":2021}